美国 · 平台与数据 · Stocktwits
Novo CEO Brushes Off Post-Midterm Drug-Pricing Fears, Says ‘Our World’ Won’t Change Dramatically – NVO Stock Gains Pre-Market
CEO Mike Doustdar told CNBC that while the company has experienced weak growth in the past due to pricing, volumes have grown ‘phenomenally.’ ...
在 Stocktwits 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)
